Show simple item record

dc.contributor.authorSharma, Ajay
dc.contributor.authorTandon, Ashish
dc.contributor.authorTovey, Jonathan C.K.
dc.contributor.authorGupta, Rangan
dc.contributor.authorRobertson, J. David
dc.contributor.authorFortune, Jennifer A.
dc.contributor.authorKlibanov, Alexander M.
dc.contributor.authorCowden, John W.
dc.contributor.authorRieger, Frank G.
dc.contributor.authorMohan, Rajiv R.
dc.date.accessioned2013-11-15T16:55:01Z
dc.date.available2013-11-15T16:55:01Z
dc.date.issued2011-08
dc.date.submitted2010-10
dc.identifier.issn15499634
dc.identifier.urihttp://hdl.handle.net/1721.1/82126
dc.description.abstractThis study examined the gene transfer efficiency and toxicity of 2-kDa polyethylenimine conjugated to gold nanoparticles (PEI2-GNPs) in the human cornea in vitro and rabbit cornea in vivo. PEI2-GNPs with nitrogen-to-phosphorus ratios of up to 180 exhibited significant transgene delivery in the human cornea without altering the viability or phenotype of these cells. Similarly, PEI2-GNPs applied to corneal tissues collected after 12 hours, 72 hours, or 7 days exhibited appreciable gold uptake throughout the rabbit stroma with gradual clearance of GNPs over time. Transmission electron microscopy detected GNPs in the keratocytes and the extracellular matrix of the rabbit corneas. Additionally, slit-lamp biomicroscopy in live animals even 7 days after topical PEI2-GNP application to the cornea detected no inflammation, redness, or edema in rabbit eyes in vivo, with only moderate cell death and immune reactions. These results suggest that PEI2-GNPs are safe for the cornea and can potentially be useful for corneal gene therapy in vivo.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (RO1EB000244)en_US
dc.description.sponsorshipResearch to Prevent Blindness, Inc. (United States)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.nano.2011.01.006en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alike 3.0en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.sourcePMCen_US
dc.titlePolyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the corneaen_US
dc.typeArticleen_US
dc.identifier.citationSharma, Ajay, Ashish Tandon, Jonathan C.K. Tovey, Rangan Gupta, J. David Robertson, Jennifer A. Fortune, Alexander M. Klibanov, John W. Cowden, Frank G. Rieger, and Rajiv R. Mohan. “Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.” Nanomedicine: Nanotechnology, Biology and Medicine 7, no. 4 (August 2011): 505-513.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.mitauthorKlibanov, Alexander M.en_US
dc.contributor.mitauthorFortune, Jennifer A.en_US
dc.relation.journalNanomedicine: Nanotechnology, Biology and Medicineen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsSharma, Ajay; Tandon, Ashish; Tovey, Jonathan C.K.; Gupta, Rangan; Robertson, J. David; Fortune, Jennifer A.; Klibanov, Alexander M.; Cowden, John W.; Rieger, Frank G.; Mohan, Rajiv R.en_US
dc.identifier.orcidhttps://orcid.org/0000-0003-3830-714X
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record